Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://emphycorp.com/sitemap_index.xml # --------------------------- # END YOAST |
Title | Emphycorp Inc Creating the future of Non-Steroidal Nasal |
Description | We are driven to create safer Nasal Spray drugs that provide a better quality of life for EmphyCorp Inc is a Private NJ Biotech focused on Providing Safer Rx Nasal Spray Drugs with no known side effects for the treatment of major Respiratory Diseases and COVID-19, including Pulmonary Fibrosis, Cystic Fibrosis, COPD, Flu, COVID-19, and |
Keywords | N/A |
WebSite | emphycorp.com |
Host IP | 74.112.255.194 |
Location | United States |
Site | Rank |
US$1,285,455
Last updated: 2023-05-08 00:17:28
emphycorp.com has Semrush global rank of 8,233,900. emphycorp.com has an estimated worth of US$ 1,285,455, based on its estimated Ads revenue. emphycorp.com receives approximately 148,322 unique visitors each day. Its web server is located in United States, with IP address 74.112.255.194. According to SiteAdvisor, emphycorp.com is safe to visit. |
Purchase/Sale Value | US$1,285,455 |
Daily Ads Revenue | US$1,187 |
Monthly Ads Revenue | US$35,598 |
Yearly Ads Revenue | US$427,167 |
Daily Unique Visitors | 9,889 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
emphycorp.com. | A | 300 | IP: 74.112.255.194 |
emphycorp.com. | NS | 86400 | NS Record: ns2.huntergrafx.net. |
emphycorp.com. | NS | 86400 | NS Record: ns1.huntergrafx.net. |
emphycorp.com. | MX | 300 | MX Record: 0 emphycorp.com. |
emphycorp.com. | TXT | 14400 | TXT Record: v=spf1 +a +mx +ip4:74.112.255.184 +ip4:74.112.255.194 ~all |
United States Canada Mexico China Middle East Japan Europe Sales Marketing About Us About Us Management and Advisors OUR MEDICAL STUDIES Our Drug Pipeline Our Drug Pipeline PULMONARY FIBROSIS TREATMENT® COVID-19 TREATMENT® COVID-19 LONG HAULERS TREATMENT® FLU TREATMENT® UNMET NEEDS BREATHING TREATMENT® NON-STEROIDAL COPD NASAL SPRAY® 70% LOWER STEROID COPD® NON-STEROIDAL ALZHEIMER’S NASAL SPRAY® CONCUSSIONS TREATMENT® DRUG FREE CANCER PRE-TREATMENT® SMOKING CESSATION ORAL SPRAY® Conditions We Can Treat HYPOXEMIA PULMONARY FIBROSIS COVID-19 COVID LONG HAULERS FLU ASTHMA COPD EMPHYSEMA SARCOIDOSIS CYSTIC FIBROSIS (CF) CHRONIC BRONCHITIS INTERSTITIAL LUNG DISEASE VIRAL and BACTERIAL Infections FDA Submissions REGULATION OF NITRIC OXIDE SODIUM PYRUVATE N115 FDA SUBMISSIONS Contact Us Investor Relations Partnerships News/Press/Blog Emphycorp News & Peer Reviewed Articles PRESS RELEASES Blog NEW PULMONARY FIBROSIS TREATMENT United States Canada Mexico China Middle East Japan Europe Sales |
HTTP/1.1 303 See other Date: Fri, 29 Oct 2021 00:43:52 GMT Server: Apache Set-Cookie: 3256d0151a3443412c2d8ed7c940534b=o6cq6oh36njsabi2gpkk63vju2; path=/; secure Location: https://emphycorp.com/ Content-Type: text/html; charset=utf-8 HTTP/1.1 200 OK Date: Fri, 29 Oct 2021 00:43:53 GMT Server: Apache P3P: CP="NOI ADM DEV PSAi COM NAV OUR OTRo STP IND DEM" Cache-Control: no-cache Pragma: no-cache Set-Cookie: 3256d0151a3443412c2d8ed7c940534b=4aav98rdvq55vf8u81iu0nq9t5; path=/; secure Content-Type: text/html; charset=utf-8 |
Domain Name: EMPHYCORP.COM Registry Domain ID: 96712309_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domain.com Registrar URL: http://www.domain.com Updated Date: 2021-01-04T15:56:18Z Creation Date: 2003-04-11T13:42:38Z Registry Expiry Date: 2027-04-11T13:42:38Z Registrar: Domain.com, LLC Registrar IANA ID: 886 Registrar Abuse Contact Email: compliance@domain-inc.net Registrar Abuse Contact Phone: 602-226-2389 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.HUNTERGRAFX.NET Name Server: NS2.HUNTERGRAFX.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T15:33:39Z <<< |